Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z6OI
|
||||
Former ID |
DNCL003434
|
||||
Drug Name |
DS-6930
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Discontinued in Phase 1 | [549405] | ||
Company |
Daiichi Sankyo
|
||||
Target and Pathway | |||||
Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | Modulator | [549406] | |
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.